Additionally, AKT phosphorylation, which is closely associated with cell survival and proliferation, was significantly downregulated following nobiletin treatment, indicating its potential to suppress pro-survival signaling in both human BPH cell lines. Here, AKT1 is linked to benign prostatic hyperplasia.